Clinical Trial Update: Indirect Comparison Topotecan Cervical Carcinoma

View source ↗

Summary

The clinical trial NCT01345279 evaluating topotecan for cervical intraepithelial neoplasia has completed, with results reported via an indirect comparison.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cervical Intraepithelial Neoplasia | Status: COMPLETED